Trump's India visit: Officials rushing to create a trade agreement

A visit by Trump's right hand man for trade negotiations - United States Trade Representative Robert Lighthizer - also remains uncertain

Prime Minister Narendra Modi meeting the US President Donald Trump, at the delegation level talks at White House, in Washington DC
Prime Minister Narendra Modi meeting the US President Donald Trump, at the delegation level talks at White House, in Washington DC. Photo: PTI
Subhayan Chakraborty New Delhi
2 min read Last Updated : Feb 13 2020 | 2:13 AM IST
Officials are scrambling to create a trade pact, to be signed with US President Donald Trump, before his visit.
 
On Tuesday, Trump said he would sign a trade agreement with India during his visit only if it was the “right deal”. However, with the US demanding broad trade concessions across multiple sectors such as agriculture, information technology, and automobiles, talks have reached a stalemate, multiple officials said on Wednesday.
 
A visit by Trump’s right hand man for trade negotiations — United States Trade Representative Robert Lighthizer — also remains uncertain. Lighthizer was set to attend a crucial meeting in New Delhi this week to iron out trade issues, but no official confirmation was put out, as of Wednesday.  People in the know say the government is now betting on a compromise on agri trade, which may see India systematically revoking high import duties on key agricultural produce such as almonds, walnut, apples, and wine, on which New Delhi had raised duties by up to 50 per cent last year. Farm lobbies have pressurised the government to restrict market access for these products. “Discussions on other American demands — lower duties for industrial components, engineering products, and tech goods like smartwatches and iPhones — are lengthy and not expected to be completed by the time of Trump’s visit,” an official said.
 
While both sides are working on a “comprehensive trade package”, US trade officials have expressed their displeasure with New Delhi’s decision to saddle medical device imports with an additional health cess.
 
India has refused to roll it back, but people in the know say the government may allow a trade margin policy for specific high-value items like coronary stents. Further, the US on Tuesday classified India as a developed economy, making it ineligible for trade benefits to developing nations. As a result, chances of India reclaiming trade benefits under the US’ Generalized System of Preferences (GSP) that it has hitherto received has been quashed.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Trump's India visittrade agreementsDonald TrumpGeneralized System of Preferences

Next Story